Synedica
Synedica has become a search term associated with peptide research, research products, formulations and biotechnology information. For people searching for product details, UK pricing, Retatrutide research or peptide information, understanding the catalogue and its different product categories is an important first step.
This guide brings together the main research topics, products, pricing information and UK context in one place.
What Is Synedica?
Synedica is associated with a collection of peptide research materials and biotechnology-related formulations covering areas such as metabolic research, cellular signalling, skin-focused research and other specialist research categories.
The UK-focused research resource is designed to organise product information and educational material around individual compounds, formulations and research topics.
Rather than treating every product as the same type of research material, visitors can explore individual listings to review the stated formulation, quantity, format and current catalogue information.
Synedica Research
Peptides are an important subject within modern biomedical research.
Researchers study peptides because their molecular structures can interact with specific biological targets and signalling pathways. Research may examine:
- Receptor interactions
- Cellular signalling
- Molecular pathways
- Structure-function relationships
- Metabolic pathways
- Peptide combinations
- Formulation characteristics
- Laboratory research applications
The research catalogue brings together products associated with several of these areas.
Synedica Products
The current online catalogue contains a range of products and formulations.
Examples currently listed include:
- Retatrutide 40mg
- CagriReta
- CagriSema
- Tirzepatide
- Semaglutide
- Somatotropin
- BPC-157 & TB-500
- Klow Skin
- NAD+ & NMN
- NAD+ & B12
- Biotin
- Glow Skin
- Melanotan II
- TRT & HCG
The live shop currently shows 15 catalogue results, with prices varying according to product, formulation and quantity.
Current Synedica Price Guide
For visitors comparing catalogue prices, the current listings provide useful reference points.
| Product | Current listed price |
|---|---|
| Retatrutide 40mg Triple Agonist Pen | £110 |
| Retatrutide 40mg Bulk | £130–£6,200 |
| CagriReta Dual Pen | £120 |
| CagriSema Dual Pen | £80 |
| Klow Skin 80mg | £110 |
| Tirzepatide Dual Agonist Pen | £110 |
| Semaglutide Pen Kit | £115 |
| Somatotropin Pen Kit | £100 |
| BPC-157 & TB-500 Pen Kit | £100 |
| NAD+ & NMN Dual Action Pen | £100 |
| NAD+ & B12 Dual Action Pen | £100 |
| Biotin Pen | £100 |
| Glow Skin Multi-Peptide Pen | £115 |
| Melanotan II Nasal Spray | £50 |
These prices reflect the current online catalogue and may change. Buyers should check the individual product page for the latest price and product information.
Synedica Retatrutide
Retatrutide is one of the most prominent research topics associated with the catalogue.
Retatrutide is an investigational compound studied for activity involving three receptor pathways:
GIP + GLP-1 + glucagon
This triple-receptor activity is one reason retatrutide has attracted considerable scientific and commercial interest.
The current catalogue lists a 40mg Retatrutide Triple Agonist Injection Pen Kit at £110 and a separate Retatrutide 40mg Bulk Price listing at £130–£6,200, depending on the selected quantity.
Retatrutide 40mg Price
For someone specifically searching for Retatrutide 40mg price UK, the current catalogue reference is:
40mg pen: £110
Bulk listing: £130–£6,200
These are separate catalogue listings and should be compared according to their individual format and quantity.
Is Retatrutide Approved in the UK?
Retatrutide remains under clinical development.
The MHRA’s current records show a paediatric investigation plan for retatrutide relating to obesity, published on 16 July 2026. An investigation plan indicates ongoing regulatory development activity; it does not itself constitute marketing authorisation for general medical use.
This distinction is important when searching for retatrutide products online.
Research-product listings should not automatically be interpreted as evidence that a compound is an authorised medicine.
Synedica Peptides
The peptide category covers multiple areas of research.
Some of the catalogue’s products contain individual peptides, while others are presented as multi-component formulations.
Examples include:
BPC-157 & TB-500
The catalogue lists a combined product containing 40mg total, with the product description specifying 30% BPC-157 and 70% TB-500. The current listed price is £100.
Glow Skin Multi-Peptide
The current catalogue lists a formulation containing GHK-Cu, BPC-157 and TB-500, with 112mg total stated in the product description. The listed price is £115.
Klow Skin
Klow Skin is another skin-focused formulation in the catalogue, currently listed at £110 for the 80mg product.
Synedica UK
The website describes itself as an independent UK-focused resource covering research materials, formulations and emerging biotechnology.
Searches such as:
- Synedica UK
- Synedica research UK
- Synedica peptides UK
- Synedica products UK
- Synedica price UK
- Retatrutide UK research
can therefore be addressed through dedicated pages within the wider content structure.
For UK regulatory questions, however, official MHRA information should take priority over commercial websites.
How to Compare Research Products
If you are researching different catalogue products, price should only be one consideration.
1. Product identity
Confirm the exact product name.
2. Stated quantity
Check the total quantity shown in the product description.
3. Formulation
Review whether the listing contains a single compound or multiple components.
4. Product format
Different listings may use different formats, such as injection pens or nasal-spray products.
5. Documentation
Review available product documentation and analytical information where provided.
6. Current price
Online prices can change. Always verify the live listing before relying on a price published elsewhere.
7. Research-use status
Understand the stated purpose and restrictions associated with research materials.
Synedica Catalogue
The catalogue can be viewed as several interconnected research categories.
Metabolic research
This includes products such as Retatrutide, Tirzepatide and Semaglutide.
Peptide research
This includes products associated with BPC-157, TB-500 and other peptide formulations.
Skin-focused research
Klow Skin and Glow Skin are examples of products presented within this category.
Cellular and cofactor research
NAD+, NMN, B12 and Biotin products represent another area of the catalogue.
This structure makes it possible to create dedicated research pages around individual compounds rather than forcing every topic into one general article.
Why People Search for Synedica
Search intent around the term can vary considerably.
Someone searching simply for Synedica may want general information.
Someone searching Synedica products is probably looking for the catalogue.
Someone searching Synedica price is looking for commercial information.
Someone searching Synedica Retatrutide 40mg is looking for a specific product.
Someone searching Synedica UK may want UK-focused information.
Someone searching Retatrutide 40mg pen price UK has an even more specific commercial query.
That makes a structured content cluster useful for covering the different stages of search intent.
Research-Use Notice
The catalogue and research information should be understood within the stated research-use context.
Research materials should not be represented as approved medicines or as substitutes for regulated medical treatment.
This article does not provide dosing instructions, treatment recommendations or medical advice.
For questions concerning medicines, treatment or personal health decisions, appropriate regulated healthcare channels should be used.
Frequently Asked Questions
What is Synedica?
Synedica is associated with a collection of peptide research materials, formulations and biotechnology-related information.
What products are listed?
The current catalogue includes Retatrutide, CagriReta, CagriSema, Tirzepatide, Semaglutide, Somatotropin, BPC-157 & TB-500, Klow Skin, NAD+ products, Biotin and other research formulations.
How much is Retatrutide 40mg?
The current catalogue lists the 40mg Retatrutide Triple Agonist Injection Pen at £110. A separate 40mg bulk listing displays £130–£6,200, depending on quantity.
Is Retatrutide approved in the UK?
Retatrutide remains under clinical development. The MHRA currently records a paediatric investigation plan for retatrutide relating to obesity.
Where can I find current product prices?
The live catalogue and individual product pages provide the current listed prices. Prices can change, so older articles should not be treated as definitive price lists.
Are the products medicines?
Research products should not automatically be considered medicines. Regulatory status and intended use must be considered separately for each compound.
Explore the Research Hub
Use this page as the central entry point to the wider content cluster:
Synedica Research — research and educational information
Synedica Products — catalogue and product overview
Synedica Peptides — peptide-focused research information
Synedica UK — UK-focused information
Synedica Price — pricing and catalogue guide
Synedica Retatrutide — Retatrutide research information
Retatrutide 40mg Pen Price UK — specific commercial-intent search
Buy Retatrutide 40mg — purchasing and catalogue guide
Final Takeaway
The Synedica research catalogue covers multiple peptide and biotechnology-related categories, from Retatrutide and other metabolic research compounds to skin-focused and cellular research formulations.
For visitors researching the catalogue, the best approach is to evaluate each product individually, checking its stated formulation, quantity, documentation, current price and research-use context.
For UK regulatory information, official MHRA records should be consulted separately from commercial product listings.
Research-use notice: This content is provided for scientific and informational purposes. Research materials discussed here are not presented as approved medicines or medical treatments. Nothing on this page constitutes medical advice, diagnosis, treatment advice or a recommendation for human or veterinary use.
